P554: A case series of 17 patients with VEXAS syndrome due to UBA1 Met41 variants

P554: A case series of 17 patients with VEXAS syndrome due to UBA1 Met41 variants

Bibliographic Details
Main Authors:	Alicia Scocchia, Allison Sluyters, Margarita Andreevskaya, Kirsi Alakurtti, Paivi Kokkonen, Kimberly Gall, Julie Hathaway, Victoria Howell, Lotta Koskinen, Janica Djupsjöbacka, Massimiliano Gentile, Pertteli Salmenperä, Jussi Paananen, Samuel Myllykangas, Juha Koskenvuo
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Genetics in Medicine Open
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949774423006015

Similar Items

P626: Clinical utility of structural variant calling using breakpoint analysis method for targeted NGS gene panels
by: Lotta Koskinen, et al.
Published: (2024-01-01)

P622: Genetic results in a cohort of 489 patients with inherited myopathies
by: Kim Gall, et al.
Published: (2024-01-01)

P577: Genetic findings in afor cohort of over 1,800 patients tested with a combined cardiomyopathy and arrhythmia panel*
by: Julie Hathaway, et al.
Published: (2024-01-01)

P487: Genetic findings from multi-gene panel for primary ciliary dyskinesia
by: Victoria Howell, et al.
Published: (2023-01-01)

Diagnostic yield of genetic testing in a multinational heterogeneous cohort of 2088 DCM patients
by: Krista Heliö, et al.
Published: (2023-09-01)

P465: The occurrence of noncoding variants, copy number variants and variants in difficult-to-sequence genes in over 10,000 whole exome sequencing tests
by: Kimberly Gall, et al.
Published: (2023-01-01)

Recurrent Mutations of the Active Adenylation Domain of UBA1 in Atypical Form of VEXAS Syndrome
by: Alyx Faurel, et al.
Published: (2023-04-01)

Next-generation sequencing in childhood-onset epilepsies: Diagnostic yield and impact on neuronal ceroid lipofuscinosis type 2 (CLN2) disease diagnosis.
by: Kimberly Gall, et al.
Published: (2021-01-01)

De-escalation of corticosteroids and clonal remission in UBA1 mutation-driven VEXAS syndrome with 5-azacytidine
by: Roochi Trikha, et al.
Published: (2024-06-01)

A novel XNA-based Luminex assay to detect UBA1 somatic mutations associated with VEXAS syndrome
by: Yunqing Ma, et al.
Published: (2024-03-01)

P778: A CARTOGRAPHY OF UBA1 GENE TESTING, EPIDEMIOLOGY AND CLINICAL-GENOMIC CHARACTERISTICS: THE VEXAS ITALIAN EXPERIENCE
by: Carmelo Gurnari, et al.
Published: (2023-08-01)

UBA1 Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic Leukemia
by: Carmelo Gurnari, et al.
Published: (2022-10-01)

Think VEXAS: a case report of Vexas syndrome
by: T. Najdi, et al.
Published: (2024-11-01)

VEXAS syndrome with p.Met41Leu UBA1 gene mutation misdiagnosed as tumid lupus: A series of 3 cases
by: Alicia Mizes, MD, et al.
Published: (2025-03-01)

Dominance of an <i>UBA1</i> mutant clone over a <i>CALR</i> mutant clone: from essential thrombocytemia to VEXAS.
by: Mehdi Hage-Sleiman, et al.
Published: (2021-07-01)

Exome sequencing can misread high variant allele fraction of somatic variants in UBA1 as hemizygous in VEXAS syndrome: a case report
by: Matheus V. M. B. Wilke, et al.
Published: (2022-08-01)

VEXAS Syndrome—Review
by: Zhang Zhang, et al.
Published: (2023-09-01)

Diagnostic yield of genetic testing in a heterogeneous cohort of 1376 HCM patients
by: Julie Hathaway, et al.
Published: (2021-03-01)

Azacytidine Treatment for VEXAS Syndrome
by: Marc H. G. P. Raaijmakers, et al.
Published: (2021-12-01)

VEXAS syndrome with cutaneous nodules
by: Yahya Argobi
Published: (2021-12-01)

GRINL1A Complex Transcription Unit Containing GCOM1, MYZAP, and POLR2M Genes Associates with Fully Penetrant Recessive Dilated Cardiomyopathy
by: Krista Heliö, et al.
Published: (2021-11-01)

Clinical Images: Ureteritis in VEXAS syndrome
by: Arupam Raman, et al.
Published: (2024-06-01)

VEXAS syndrome: a diagnostic puzzle
by: Martin Krusche, et al.
Published: (2023-07-01)

AMT 554 - Pengurusan Projek 3
by: PPPB, Pusat Pengajian Perumahan Dan Bangunan
Published: (1995)

Case report: VEXAS syndrome and literature review
by: Can Jones, et al.
Published: (2024-11-01)

VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia
by: Janne Austestad, et al.
Published: (2023-01-01)

VEXAS without vacuoles: Linking genotype to phenotype
by: Sara Zhukovsky, et al.
Published: (2024-10-01)

VEXAS Syndrome: A Novelty in MDS Landscape
by: Marie Templé, et al.
Published: (2022-06-01)

Vexas syndrome: a new hematoinflammatory disease
by: Roberto Michael Blanco-Alvarez, et al.
Published: (2023-07-01)

Digital Track Map for the VEXA expert system
by: Adam Hlubuček
Published: (2022-05-01)

VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
by: Huijun Huang, et al.
Published: (2021-03-01)

UBA 200
by: Fernando Gandolfi
Published: (2022-12-01)

Ubá, Belenenses
by: Eduardo Frigatti
Published: (2020-12-01)

Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry
by: Antonio Vitale, et al.
Published: (2025-02-01)

Biallelic loss-of-function in NRAP is a cause of recessive dilated cardiomyopathy.
by: Juha W Koskenvuo, et al.
Published: (2021-01-01)

Histerectomias: estudo retrospectivo de 554 casos
by: Eddie Fernando Cândido Murta, et al.

Very long-term remission with azacitidine in VEXAS syndrome
by: Lin-Pierre Zhao, et al.
Published: (2025-01-01)

VEXAS syndrome: on the threshold of changing perceptions of known diseases
by: B. D. Chaltsev, et al.
Published: (2023-12-01)

A new disorder to keep in mind: VEXAS syndrome
by: Egídio Freitas, et al.
Published: (2024-04-01)

VEXAS syndrome: Focus on dermatological manifestations and their histopathological correlate
by: Sofie Engelen, et al.
Published: (2024-09-01)